VitaNova Life Sciences generated $321,576 in Revenue for the three months ended July 31, 2026, versus $103,899 a year earlier, while net loss reached $123,101. The figures matter to investors because healthy food products supplied $234,576 of revenue, but total current liabilities were $311,656.

Key Highlights

  • Revenue totaled $321,576 for the three months ended July 31, 2026.
  • Healthy food products generated $234,576 of VitaNova Life Sciences’ quarterly revenue.
  • Cash stood at $1,604,182 on July 31, 2026.

Net loss reached $123,101, versus a net loss of $46,301 a year earlier. Revenue was $321,576 in the latest quarter, compared with $103,899 in the comparable 2025 quarter. Revenue came from healthy food products and dietary supplement products during the latest period.

Quarterly Results Show Wider Loss

In the comparable 2025 quarter, cost of revenue was $35,118 and Gross Profit was $68,781. Income from operations was a loss of $122,162 in the latest quarter, compared with an operating loss of $32,440 in the prior-year period. Net loss was $123,101, while the corresponding 2025 loss was $46,301. The weighted average basic share count was 8,337,454 in both periods.

Healthy Food Products and Dietary Supplements

Healthy food products contributed $234,576 in revenue during the latest quarter, while dietary supplement products generated $87,000. The comparable quarter included $99,674 from dietary supplement products and $4,225 from consulting service income. That period’s total revenue was $103,899. The healthy food products segment recorded gross profit of $6,701, while dietary supplement products produced gross profit of $23,820. Segment losses were $93,066 for healthy food products and $29,096 for dietary supplement products.

Cash and Current Assets

Cash was $1,604,182 at July 31, 2026, compared with $1,597,217 at April 30, 2026. Accounts receivable, net, stood at $316,871, while inventories were $301,294. Total current Assets were $2,223,297 at July 31, 2026. The balance included $950 in other current assets and $16,038 in deferred tax assets outside current assets. Total current liabilities were $311,656. Accounts Payable represented $122,805, accrued expenses and other current liabilities were $79,903, and income tax payable was $108,948. Total assets were $2,239,335, while total liabilities were $311,656. At April 30, 2026, total current assets were $2,430,523 and total current liabilities were $395,781. The filing states that VitaNova may seek additional financing to the extent needed.